24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Melioidosis in Tsunami Survivors

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To the Editor: A tsunami devastated coastal areas of the Indian Ocean rim in December 2004. Of the affected countries, more than half of the ≈300,000 deaths occurred in the Aceh Province of Indonesia, close to the epicenter of the earthquake near northern Sumatra. Infrastructure, including medical and laboratory facilities, in this region was severely damaged. Of >1,000,000 survivors, >500,000 likely were injured. Most injuries were from trauma, but a substantial number were caused by aspiration of, or immersion in, saltwater that may have been contaminated by soil, sewage, or other environmental sources. Melioidosis, caused by the saprophytic gram-negative bacillus Burkholderia pseudomallei, is endemic in Southeast Asia and northern Australia. Most cases have been found in northeastern Thailand, Singapore, and northern Australia. Melioidosis has been reported only sporadically from Indonesia and mainly in returning travelers ( 1 – 3 ). In the context of acute medical relief efforts to the town of Banda Aceh, we report on 10 patients with pneumonia, including 4 patients with culture-confirmed melioidosis, after their immersion in contaminated saltwater during the tsunami. Clinical and laboratory services were reestablished on January 3, 2005, at Fakinah Hospital and on January 13, 2005, at Zainoel Abidin Hospital by the relief teams. Patients were identified opportunistically; details of treatment and outcome were reviewed retrospectively. Cultures were taken when clinically indicated and when specimens were available. Sputum cultures were plated onto horse blood agar, cystine lactose electrolyte-deficient agar, Haemophilus agar, and colistin/nalidixic acid blood agar incubated in a candle jar at 35°C for <3 days. Colonies suspicious for B. pseudomallei were subcultured to B. cepacia–selective media (Oxoid, Adelaide, South Australia, Australia). Blood cultures and screening cultures of throat and rectum specimens were not performed routinely. Isolates of B. pseudomallei and characteristic antimicrobial drug susceptibilities were confirmed with API20NE (bioMérieux, Marcy l'Etoile, France). From January 3 to January 28, 2005, a total of 10 cases of postimmersion pneumonia were identified. All patients were <18 years of age and previously well; 6 were male. No cases were epidemiologically linked to others. The patients were treated 10–35 days after the tsunami. Eight had bilateral alveolar opacities on chest radiograph; 3 also had empyema. Clinical, radiologic, and microbiologic details are summarized in the Table. Table Clinical details of pneumonia patients after tsunami in Banda Aceh, Indonesia, January 2003* Patient no. Age (y)/sex Radiograph results Complications Microbiologic test results Days before treatment Antimicrobial drug Acute outcome 1 7/M Bilateral infiltrates Cavitation No cultures taken 19 Meropenem Fever resolved, improving @30 days 2 12/M Bilateral infiltrates Pseudomonas aeruginosa (sputum) 37 Meropenem Serious but stable @12 days 3 5/M Unilateral infiltrates Cavitation No cultures taken 10 Meropenem Fever resolved, improving @39 days 4 15/F Bilateral infiltrates Pneumothorax, empyema Burkholderia pseudomallei (sputum) 27 Meropenem 2 wks, then oral TMP-SMX and coamoxiclav Fully recovered, discharged @20 days 5 14/M Bilateral infiltrates P. aeruginosa (sputum) 35 Meropenem Improving @11 days 6 6/M Bilateral infiltrates P. aeruginosa (sputum) 30 Meropenem Improving @19 days 7 18 mo/M Bilateral infiltrates Empyema B. pseudomallei (pleural fluid) 30 Meropenem Improving @23 days 8 10/F Bilateral infiltrates Empyema P. aeruginosa
B. pseudomallei
Klebsiella sp. (pleural fluid) 30 Meropenem Improving @23 days 9 13/F Bilateral infiltrates P. aeruginosa
B. pseudomallei (sputum) 33 Meropenem Improving @18 days 10 17/F Unknown Unknown Nocardia spp. (sputum) 21 Ticarcillin/clavulanate, ciprofloxacin Not improving, outcome unknown @12 days *ICU, intensive care unit; TMP-SMX, trimethoprim-sulfamethoxazole. The sputum cultures of 4 patients were positive for B. pseudomallei. Except posttsunami exposure, none had risk factors for melioidosis, including diabetes, renal failure, or thalassemia. Other co-isolated organisms included Pseudomonas aeruginosa and Klebsiella sp.; 2 patients who did not have cultures taken had cavitatory lung disease. All patients with melioidosis were treated with meropenem, and all but 1 clinically improved in the hospital. This is the second report of melioidosis from within Indonesia ( 1 ) and the second published report of melioidosis after the tsunami disaster ( 4 ). Cases from this event were included in a preliminary communication ( 5 ). However, exported cases of melioidosis from Indonesia, as well as the neighboring countries of Singapore and Malaysia, have been reported previously ( 2 , 3 ), a likely indication that this infection is underrecognized in Indonesia. Melioidosis has also been reported in tsunami survivors from Sri Lanka ( 4 ) and Thailand. A striking feature of this event is the lack of predisposing factors and the young age of the patients. This feature likely represents the unique mode of acquisition and magnitude of the infecting inoculum, as well as the vulnerability of children to near drowning after flooding. One third of the patients had empyema, which reflects both the severity of pulmonary disease and delay in receiving medical care. Undoubtedly, a substantial selection bias occurred by including only patients who sought hospital treatment, and this is suggested by the low death rate. Melioidosis, acquired after near drowning, has been associated with a short incubation period and severe disease. However, patients who had melioidosis before medical aid arrived in the region would likely have died. Patients with longer incubation periods also may have acquired melioidosis through contaminated wounds with subsequent hematogenous dissemination. Medical services to the region were by no means comprehensive during this time. Many other patients with postimmersion pneumonia and melioidosis may have been overlooked, both during the study (for persons who were not treated or if cultures were not taken) and afterwards; the incubation period of melioidosis may be <62 years. A further limitation is the lack of denominator data because no reliable records were kept on hospital admissions, and the exact number of survivors is not yet known. Conflicting data are found on the accuracy of the API20NE test kit used to identify bacteria in this study ( 6 – 9 ), but we believe that the clinical features and microbiologic findings suggest melioidosis. This report confirms that B. pseudomallei exists in the Aceh Province of Indonesia and that melioidosis and gram-negative pneumonia may complicate saltwater immersion in this region. After near drowning incidents, melioidosis is characterized by severe pulmonary disease, including pleural effusions. Clinicians worldwide should be mindful that melioidosis in tsunami survivors may appear many years after exposure.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

          The API 20NE kit and a simple screening system involving Gram's stain, the oxidase reaction, colistin and gentamicin resistance, and colonial characteristics on a differential agar medium, were used to test 400 strains of Pseudomonas pseudomallei. The API kit identified 390 (97.5%) strains correctly on first testing and all but one of the remainder on second testing. Only one strain was initially misidentified (as Ps cepacia). The screening system was 100% accurate in identifying Ps pseudomallei. In non-endemic areas the API 20NE kit may be used to identify sporadic imported strains of Ps pseudomallei. Such kits may also help to delineate the geographical distribution of melioidosis. In endemic areas the screening tests described offer a cheap, simple, and accurate means of presumptively identifying Ps pseudomallei from clinical specimens.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei.

            The identification of Burkholderia pseudomallei, the causative agent of melioidosis, is usually not difficult in laboratories in areas where it is endemic. With the increase in international travel and the threat of bioterrorism, it has become more likely that laboratories in areas where it is not endemic could encounter this organism. The increase in the use of and dependence upon automated identification systems makes accurate identification of uncommonly encountered organisms such as B. pseudomallei critically important. This study compares the manual API 20NE and 20E identification systems with the automated Vitek 1 and 2 systems. A total of 103 B. pseudomallei isolates were tested and correctly identified in 98%, 99%, 99%, and 19% of cases, respectively. The failure of the Vitek 2 to correctly identify B. pseudomallei was largely due to differences in the biochemical reactions achieved compared to expected values in the database. It is suggested that this deficiency in the Vitek 2 may be due to the large number of uncertain results reported for these isolates. These results reduce the discriminating ability of the instrument to distinguish between uncommonly encountered isolates such as those of B. pseudomallei.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Potential misidentification of Burkholderia pseudomallei by API 20NE.

              Biochemical confirmation of the identity of Burkholderia pseudomallei in Singapore previously relied on the API 20NE panel of tests. After introducing an alternative proprietary biochemical panel, the Microbact 24E (MedVet, Adelaide, Australia), we noted that the API panel identified some presumptive B. pseudomallei isolates as other species. We therefore compared the performance of the API 20NE against the Microbact 24E with 50 distinct clinical isolates of B. pseudomallei, after 24 hours and after five days incubation of primary cultures. The API panel correctly identified 40 isolates. Four results were unacceptable or uninterpretable. Six isolates were misidentified as other species; the commonest being Chromobacterium violaceum. One of these was again identified as C. violaceum by the repeat API panel. Fourteen isolates, including the six misidentified isolates and four isolate pairs from separate sources in four separate patients, were typed using PCR amplification of repetitive extragenic palindromic sequences (REPS). The isolates identified as C. violaceum appeared to have identical REPS patterns, suggesting that some of the errant API results may be due to a single locally prevalent strain of B. pseudomallei. A previous suggestion that C. violaceum may produce a melioidosis-like illness may therefore be due to laboratory misidentification of B. pseudomallei with the API 20NE biochemical test panel.
                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                Emerging Infect. Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                October 2005
                : 11
                : 10
                : 1638-1639
                Affiliations
                [* ]The Geelong Hospital, Geelong, Victoria, Australia
                []Royal Brisbane Hospital, Brisbane, Queensland, Australia
                []Queensland Health Pathology Services, Townsville, Queensland, Australia
                [§ ]Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia
                []Menzies School of Health Research, Darwin, Northern Territory, Australia
                Author notes
                Address for correspondence: Eugene Athan, Department of Infectious Diseases, The Geelong Hospital, Barwon Health, Ryrie St, Geelong 3220, Australia; fax: 61-3-5260-3040; email: eugene@ 123456barwonhealth.org.au
                Article
                05-0740
                10.3201/eid1110.050740
                3366758
                16355505
                1f6f8632-2b9e-43b5-9867-c9cf9c8dfadb
                History
                Categories
                Letters to the Editor
                Letter

                Infectious disease & Microbiology
                pneumonia,letter,tsunami,melioidosis
                Infectious disease & Microbiology
                pneumonia, letter, tsunami, melioidosis

                Comments

                Comment on this article